Marzia Del Re Selected Research

Marzia Del Re Research Topics

Disease

53	Neoplasms (Cancer) 01/2024 - 09/2010
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 05/2014
15	Breast Neoplasms (Breast Cancer) 02/2024 - 08/2012
11	Prostatic Neoplasms (Prostate Cancer) 04/2023 - 12/2014
9	Disease Progression 02/2024 - 12/2014
9	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 08/2015
5	Lung Neoplasms (Lung Cancer) 01/2024 - 12/2019
4	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 11/2017
4	Melanoma (Melanoma, Malignant) 01/2024 - 01/2018
4	Neoplasm Metastasis (Metastasis) 04/2023 - 06/2015
4	Pancreatic Neoplasms (Pancreatic Cancer) 07/2021 - 11/2017
3	Residual Neoplasm 11/2022 - 04/2022
3	Adenocarcinoma 07/2021 - 01/2015
3	Circulating Neoplastic Cells 01/2021 - 01/2019
3	Carcinoma (Carcinomatosis) 10/2020 - 08/2015
3	Neutropenia 01/2016 - 12/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 01/2022
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 03/2020
2	Inflammation (Inflammations) 01/2022 - 01/2016
2	Thyroid Neoplasms (Thyroid Cancer) 07/2021 - 01/2017
2	Drug-Related Side Effects and Adverse Reactions 07/2021 - 12/2019
2	Macular Edema 01/2018 - 01/2016
1	Fasciitis (Fascitis) 04/2024
1	Brain Neoplasms (Brain Tumor) 01/2024
1	Glioma (Gliomas) 01/2024
1	Mesothelioma 11/2023
1	Necrosis 09/2023
1	Crohn Disease (Crohn's Disease) 09/2023
1	Viremia 01/2022
1	Headache (Headaches) 01/2022

Drug/Important Bio-Agent (IBA)

14	Cell-Free Nucleic AcidsIBA 01/2024 - 05/2014
14	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2017
13	Tyrosine Kinase InhibitorsIBA 01/2021 - 05/2014
10	Immune Checkpoint InhibitorsIBA 01/2024 - 12/2019
10	Circulating Tumor DNAIBA 01/2023 - 10/2015
8	ErbB Receptors (EGF Receptor)IBA 02/2024 - 10/2015
7	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2017
7	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 11/2017
7	Messenger RNA (mRNA)IBA 01/2024 - 01/2018
6	Monoclonal AntibodiesIBA 09/2023 - 01/2018
6	Androgen Receptors (Androgen Receptor)IBA 04/2023 - 12/2014
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2014
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022 - 12/2014
6	Bevacizumab (Avastin)FDA Link 12/2019 - 12/2014
5	Hormones (Hormone)IBA 02/2023 - 01/2019
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 12/2011
3	AntibodiesIBA 01/2024 - 01/2018
3	Phosphotransferases (Kinase)IBA 11/2023 - 08/2019
3	Tamoxifen FDA LinkGeneric 02/2021 - 08/2012
3	AndrogensIBA 01/2021 - 12/2014
3	abirateroneIBA 10/2020 - 12/2014
3	EnzymesIBA 12/2019 - 12/2014
3	Interleukin-8 (Interleukin 8)IBA 12/2019 - 12/2014
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 01/2016
2	Estrogen ReceptorsIBA 02/2024 - 02/2021
2	LigandsIBA 01/2024 - 01/2023
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 07/2016
2	palbociclibIBA 12/2022 - 11/2019
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 11/2017
2	Gemcitabine FDA Link 07/2021 - 01/2021
2	130-nm albumin-bound paclitaxelIBA 07/2021 - 01/2021
2	lenvatinibIBA 07/2021 - 01/2017
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 02/2021 - 06/2017
2	enzalutamideIBA 01/2021 - 04/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 12/2014
2	Angiogenesis InhibitorsIBA 03/2020 - 08/2015
2	Cetuximab (Erbitux)FDA Link 01/2019 - 01/2016
2	Capecitabine (Xeloda)FDA Link 01/2016 - 01/2015
2	Fluorouracil (Carac)FDA LinkGeneric 01/2015 - 09/2010
1	Ubiquitin-Specific ProteasesIBA 04/2024
1	Estrogen Receptor alphaIBA 02/2024
1	Aromatase InhibitorsIBA 02/2024
1	elacestrantIBA 02/2024
1	Selective Estrogen Receptor Modulators (SERM)IBA 02/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2024
1	Interferon-gamma (Interferon, gamma)IBA 01/2024
1	TMB 6IBA 11/2023
1	trastuzumab deruxtecanIBA 11/2023
1	Immunoconjugates (Immunoconjugate)IBA 11/2023
1	adavosertibIBA 11/2023
1	regorafenibIBA 10/2023
1	trifluridine tipiracil drug combinationIBA 10/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2023
1	ribociclibIBA 12/2022
1	Proton Pump InhibitorsIBA 12/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2022
1	AutoantibodiesIBA 01/2022
1	CytokinesIBA 01/2022

Therapy/Procedure

27	Therapeutics 02/2024 - 11/2013
15	Drug Therapy (Chemotherapy) 10/2023 - 04/2012
8	Immunotherapy 01/2023 - 01/2018
6	Castration 04/2023 - 01/2017
2	Aftercare (After-Treatment) 09/2023 - 01/2015
2	Precision Medicine 01/2021 - 01/2020
2	Neoadjuvant Therapy 01/2019 - 11/2018
1	Time-to-Treatment 01/2024
1	Retreatment 01/2023
1	Molecular Targeted Therapy 04/2022
1	Radiotherapy 01/2022